Pituitary Tumour Treatment in Singapore: A Comprehensive Guide

Living with a pituitary tumour diagnosis can feel overwhelming. You may have questions about what this means for your health, what treatment options exist, and how your life might change. Pituitary tumours are frequently manageable, and many patients lead full, active lives with appropriate medical care.

 

Pituitary tumour treatment in Singapore has developed considerably. Patients now have access to diagnostic tools and therapies, including MRI scans and hormone blood tests. Your tumour may have been discovered incidentally during imaging for another condition, or you may have sought help for concerning symptoms such as headaches, vision changes, or unexplained weight gain. Understanding your condition is the first step towards taking control of your health.

 

This guide provides information about pituitary tumours, covering causes, symptoms, and treatment approaches available in Singapore. If you have concerns about pituitary health, speak with your healthcare provider about appropriate screening and evaluation options.

Dr Ng Zhi Xu
Senior Consultant Neurosurgeon
Dr Roy Koh Kiok Miang
Senior Consultant Neurosurgeon

What is a Pituitary Tumour?

A pituitary tumour is an abnormal growth in the pituitary gland, a pea-sized organ at the base of the brain, just behind the bridge of the nose. Despite its small size, the pituitary gland regulates many bodily functions, producing hormones (chemical messengers that control various body processes) that control growth, metabolism, reproduction, and stress responses.

Most pituitary tumours are benign (non-cancerous) and grow slowly. These are medically termed pituitary adenomas. They rarely spread to other parts of the body. Many people may have small pituitary tumours that never cause symptoms.

Pituitary tumours are diagnosed in Singapore and across Asia. Many are discovered incidentally when brain imaging (such as MRI or CT scans) is performed for unrelated reasons. When symptoms do occur, they may result from:

  • The tumour is pressing on nearby structures
  • Hormonal imbalances (when the body produces too much or too little of certain hormones) are caused by the tumour’s activity

Types of Pituitary Tumours

Pituitary tumours are classified based on their size and whether they produce excess hormones.

Classification by Size

  • Microadenomas are tumours measuring less than 10 millimetres in diameter. Because of their small size, they often cause minimal symptoms unless they secrete hormones. Many microadenomas are discovered incidentally and may only require monitoring rather than active treatment.
  • Macroadenomas are tumours measuring 10 millimetres or larger. These larger tumours are more likely to cause symptoms by pressing on surrounding structures, including the optic nerves, which can affect vision. They may also compress normal pituitary tissue, reducing its ability to produce necessary hormones.

Classification by Hormone Production

  • Functioning (secreting) tumours produce excess amounts of one or more pituitary hormones. The specific symptoms depend on which hormone is overproduced. Prolactinomas, which secrete prolactin, are among the types of pituitary tumours.
  • Growth hormone-secreting tumours can cause acromegaly in adults or gigantism in children. ACTH-secreting tumours can lead to Cushing’s disease. TSH-secreting tumours can result in hyperthyroidism, though these are rare.
  • Non-functioning tumours do not produce excess hormones. Symptoms from these tumours typically arise from their mass effect on surrounding structures or from reducing normal pituitary function through compression.

Causes

The exact cause of most pituitary tumours remains unknown. Research suggests that genetic mutations (changes in the DNA of cells) within pituitary cells may trigger abnormal growth, but what initiates these mutations is not fully understood.

Some pituitary tumours develop as part of inherited genetic syndromes—conditions passed down through families that increase the risk of certain diseases. Multiple Endocrine Neoplasia type 1 (MEN1) is a hereditary condition that increases the risk of tumours in the pituitary, parathyroid, and pancreas. Carney complex and familial isolated pituitary adenoma are other genetic conditions associated with pituitary tumour development.

Risk Factors

Whilst pituitary tumours can affect anyone, certain factors may increase risk:

  • Family history: Having a close relative with a pituitary tumour or related genetic syndrome
  • Age: Pituitary tumours are commonly diagnosed in adults between their thirties and sixties
  • Genetic syndromes: MEN1, MEN4, Carney complex, or McCune-Albright syndrome
  • Previous head radiation: Radiation therapy to the head for other conditions may increase risk years later

Many people who develop pituitary tumours have no identifiable risk factors. Having risk factors does not mean you will develop a tumour; lacking them doesn’t guarantee you won’t.

Signs and Symptoms

Pituitary tumour symptoms vary considerably depending on the tumour’s size, location, and whether it produces hormones. Some patients experience no symptoms at all, whilst others may have significant health impacts.

Early Stage Symptoms

In the initial stages, symptoms are often subtle and may be attributed to other causes:

  • Persistent headaches, particularly in the forehead or behind the eyes
  • Mild fatigue or decreased energy levels
  • Subtle changes in menstrual patterns for women
  • Gradual decrease in libido
  • Occasional visual disturbances, such as blurred vision or difficulty focusing

Progressive Symptoms

As tumours grow or hormone production increases, symptoms typically become more pronounced:

  • Visual field defects, particularly loss of peripheral (side) vision
  • More severe or frequent headaches
  • Significant hormonal changes affecting multiple body systems
  • Unexplained weight changes
  • Mood alterations, including anxiety or depression
  • Changes in facial features or hand/foot size with growth hormone excess
  • Easy bruising, muscle weakness, and weight gain around the midsection with cortisol excess
  • Breast discharge in non-pregnant women or reduced testosterone in men with prolactin excess

Late Stage Symptoms

Advanced cases may present with:

  • Severe vision loss or double vision
  • Pituitary apoplexy (sudden bleeding into the tumour), causing severe headache, vision changes, and hormonal crisis
  • Complete loss of pituitary function (hypopituitarism, meaning the pituitary gland can no longer produce necessary hormones)
  • Symptoms of hormone deficiency that may require replacement therapy

Experiencing these symptoms?

Consult with a qualified healthcare professional for an accurate diagnosis and to discuss treatment options tailored to your specific situation.

When to See a Doctor

Seeking timely medical attention is important for appropriate outcomes. Consider consulting a healthcare professional if you experience:

 

  • Persistent headaches that don’t respond to usual treatments
  • Visual changes, especially loss of peripheral vision (the outer edges of what you can see)
  • Unexplained hormonal symptoms (such as irregular periods, breast discharge, or sexual dysfunction)
  • Unusual changes in appearance, including enlarged hands, feet, or facial features
  • Significant unexplained fatigue, weight changes, or mood alterations

 

If you experience a sudden severe headache with vision changes, nausea, or altered consciousness, seek emergency medical care immediately. This could indicate pituitary apoplexy (a sudden bleeding or loss of blood supply to the pituitary gland).

 

During your first consultation, expect a thorough review of your medical history and symptoms. Your doctor will perform a physical examination and will likely order blood tests to measure your hormone levels and help determine whether your pituitary gland is functioning normally. Imaging studies (such as MRI or CT scans) will typically be arranged to visualise the pituitary gland.

 

Early intervention can support improved treatment outcomes. Many pituitary tumours may respond to treatment when detected before significant complications develop. Even if your symptoms seem minor, consider scheduling an evaluation for peace of mind and to help address any problems promptly.

Diagnosis and Testing Methods

Accurate diagnosis of pituitary tumours involves a combination of hormonal testing and imaging studies (such as blood tests and MRI scans). This comprehensive approach helps determine the tumour’s size, type, and impact on pituitary function.

Blood Tests

Hormone level measurements provide valuable information for diagnosis. Your doctor will typically order tests for:

  • Prolactin: Elevated in prolactinomas (tumours that produce excess prolactin, a hormone involved in milk production)
  • Growth hormone and IGF-1: Elevated in acromegaly (a condition where excess growth hormone causes abnormal growth)
  • Cortisol and ACTH: Abnormal in Cushing’s disease (a condition caused by excess cortisol, which affects metabolism and stress response)
  • Thyroid hormones (TSH, T4): To assess thyroid function (which regulates metabolism and energy levels)
  • Gonadotropins (LH, FSH) and sex hormones: To evaluate reproductive function (including fertility and sexual development)

Your doctor may need to repeat these tests or perform them under specific conditions for accuracy, such as fasting or testing at particular times of day.

Imaging Studies

  • Magnetic Resonance Imaging (MRI) with contrast is commonly used for pituitary tumours. MRI uses powerful magnets and radio waves to create detailed images of the pituitary gland and surrounding structures, allowing doctors to determine tumour size, location, and relationship to nearby tissues. Most MRI scans take a moderate amount of time and are painless.
  • Computed Tomography (CT) scans may be used when an MRI is not possible or to evaluate bony structures around the pituitary.

Visual Field Testing

A formal visual field examination assesses whether the tumour is affecting your optic nerves (the nerves that carry visual information from your eyes to your brain). This painless test maps your peripheral vision and can detect subtle deficits you might not notice in daily life.

Dynamic Hormone Testing

For certain tumour types, specialised tests evaluate hormone secretion under controlled conditions. Examples include:

  • The oral glucose tolerance test for growth hormone assessment (where you drink a sugary solution and qualified healthcare professionals take blood samples at intervals)
  • Dexamethasone suppression tests for cortisol evaluation (where you take a medication and then qualified healthcare professionals measure your cortisol levels)

Results from these tests are typically available within days to a couple of weeks, depending on the complexity of the testing required.

Treatment Options Overview

Pituitary tumour treatment in Singapore encompasses several approaches, tailored to each patient’s specific tumour type, size, and overall health status. Your doctor will set treatment goals based on your individual situation. These typically include controlling tumour growth, normalising hormone levels, preserving pituitary function, and relieving symptoms

Medications are often the first-line treatment for certain pituitary tumours, particularly prolactinomas (tumours that produce the hormone prolactin). Dopamine agonists (medications that mimic the brain chemical dopamine), such as cabergoline and bromocriptine, can be used for prolactin-secreting tumours. They may help shrink tumours whilst normalising prolactin levels. Most patients take these medications orally, typically a few times per week.

For growth hormone-secreting tumours, somatostatin analogues (medications that mimic a natural hormone that regulates growth hormone), such as octreotide and lanreotide, may help reduce hormone levels and tumour size. Healthcare providers usually administer these medications as monthly injections. Growth hormone receptor antagonists (medications that block the effects of growth hormone), like pegvisomant, may be used when other treatments are insufficient.

Patients with Cushing’s disease (a condition caused by excess cortisol production) may benefit from medications that reduce cortisol production or block its effects. Options include ketoconazole, metyrapone, osilodrostat, and pasireotide. Healthcare providers often use medical therapy for Cushing’s disease when surgery is not curative or while awaiting radiation effects.

Surgery may be considered as a treatment option for most non-prolactinoma pituitary tumours and for tumours causing significant mass effect (pressure on nearby structures). The transsphenoidal approach is commonly performed. It accesses the pituitary through the nose and sphenoid sinus (a cavity behind the nose). This method avoids the need for external incisions and typically supports faster recovery.

Endoscopic transsphenoidal surgery uses small cameras and instruments inserted through the nostrils. It provides visualisation with minimal disruption to surrounding tissues. Most patients spend a few days in the hospital following this procedure.

For very large tumours extending significantly beyond the pituitary region, a craniotomy (a procedure where the surgeon creates an opening through the skull) may occasionally be necessary. Your neurosurgeon (a doctor who specialises in brain and nervous system surgery) will discuss an appropriate approach based on your tumour’s characteristics.

Radiation therapy uses high-energy beams to target tumour cells whilst minimising exposure to surrounding healthy tissue. Healthcare providers typically reserve it for tumours that persist or recur after surgery, or when surgery is not feasible.

Stereotactic radiosurgery (including Gamma Knife and CyberKnife) delivers precisely focused radiation in a single session or a few sessions. This approach may be suitable for smaller, well-defined tumours away from critical structures like the optic nerves.

Fractionated radiotherapy delivers smaller radiation doses over several weeks. Healthcare providers may prefer this approach for larger tumours or those close to sensitive structures. Spreading the dose supports recovery of normal tissue between treatments.

Radiation effects on hormone levels typically develop gradually over months to years. Regular monitoring is important to detect and treat any resulting hormone deficiencies (when the body doesn’t produce enough of certain hormones).

When pituitary tumours or their treatment result in hormone deficiencies, replacement therapy may be necessary. This may include:

– Thyroid hormone (which regulates metabolism)
– Cortisol replacement (which helps manage stress and inflammation)
– Sex hormones (which regulate reproductive function)
– Growth hormone (which affects growth and metabolism)

The specific replacements depend on which pituitary functions are affected.

Hormone replacement is typically lifelong and requires regular monitoring to help achieve appropriate dosing. Your healthcare provider will establish specific treatment targets based on your individual health needs and risk factors. With proper management, patients on hormone replacement can maintain a good quality of life.

Not all pituitary tumours require immediate treatment. Small, non-functioning tumours that aren’t causing symptoms may be safely monitored with periodic MRI scans (imaging tests that create detailed pictures of the brain) and hormone testing. This “watchful waiting” approach avoids treatment risks whilst helping to detect any changes promptly.

Complications if Left Untreated

Without appropriate treatment, pituitary tumours can lead to several serious complications that affect multiple aspects of health.

Vision loss

Vision loss is one of the most concerning potential complications. As tumours grow, they may compress the optic chiasm (the point where the nerves from each eye meet and cross), leading to progressive visual field defects and potentially blindness. Early treatment may help preserve or restore vision, but delayed intervention may result in permanent damage.

Hormonal imbalances

Hormonal imbalances can significantly impact health over time. Excess growth hormone leads to acromegaly (a condition where the body produces too much growth hormone, causing tissues and bones to grow larger), resulting in enlarged features, joint problems, diabetes, and increased cardiovascular risk. Untreated Cushing’s disease (caused by excess cortisol, a hormone that helps regulate stress and metabolism) increases risks of diabetes, osteoporosis, infections, and cardiovascular disease. Prolactin excess (elevated levels of the hormone that normally stimulates milk production) can cause infertility and bone loss.

Pituitary failure

Pituitary failure (hypopituitarism), where the pituitary gland doesn’t produce enough hormones, may develop as growing tumours compress normal pituitary tissue. This can result in deficiencies of multiple hormones that affect energy, metabolism, stress response, and reproductive function. Severe cortisol deficiency, known as adrenal crisis, can be life-threatening.

Pituitary apoplexy

Pituitary apoplexy is a medical emergency where there is sudden bleeding into the tumour or loss of blood supply to it. This rare but serious complication can cause severe headache, vision loss, and hormonal crisis. Whilst rare, this complication highlights the importance of appropriate monitoring and treatment. Untreated pituitary tumours can significantly affect quality of life through chronic headaches, fatigue, mood changes, and the cumulative effects of hormonal dysfunction.

Outcomes differ among patients based on individual health factors.

A neurosurgeon will assess your specific situation and can recommend a suitable treatment approach for you.

To discuss your treatment options, consult with a qualified medical professional.

Prevention

Whilst pituitary tumours cannot be prevented in most cases, certain strategies may help reduce risks and support early detection.

 

If you have a family history of pituitary tumours or related genetic conditions (such as MEN1, a hereditary condition that increases the risk of tumours in hormone-producing glands), genetic counselling can help assess your risk and determine appropriate screening schedules. Early detection through regular monitoring supports timely intervention when needed.

 

Maintaining overall health supports endocrine function (how your body produces and regulates hormones). Consider:

  • Balanced nutrition
  • Regular physical activity
  • Adequate sleep
  • Stress management

 

These measures have not been proven to prevent pituitary tumour development specifically.

 

For individuals with known pituitary conditions, adherence to recommended follow-up appointments and monitoring schedules plays a vital role in ongoing care. Regular assessments allow your medical team to detect any changes early and adjust treatment as needed.

Frequently Asked Questions

Are pituitary tumours cancerous?

Most pituitary tumours are benign (non-cancerous). These tumours, called pituitary adenomas, do not spread to other parts of the body. Pituitary carcinomas (cancerous pituitary tumours) are rare. Even though most pituitary tumours are benign, they still require suitable management because they can cause significant symptoms through hormone production or compression of nearby structures.

What are the outcomes of pituitary tumour surgery?

Surgical outcomes depend on several factors:

 

  • Tumour size
  • Tumour type
  • Tumour location

For smaller tumours confined to the pituitary region, qualified neurosurgeons may achieve normalisation of hormone levels in some cases for growth hormone and ACTH-secreting tumours. Larger tumours or those extending beyond the pituitary region may have different outcomes, but surgery can still help reduce tumour size and improve symptoms. Your neurosurgeon can provide more specific information based on your individual situation and medical history.

Will I need to take medications for life after pituitary tumour treatment?

This depends on your specific situation. Some patients require no long-term medications after treatment. Others may need hormone replacement therapy (medication to replace hormones that your pituitary gland can no longer produce adequately) if their normal pituitary function is affected by the tumour or its treatment. For prolactinomas managed with medication, some patients may eventually discontinue treatment under careful medical supervision. Your doctor will monitor your hormone levels and advise on any ongoing medication needs.

How long is the recovery after pituitary surgery?

Most patients spend a few days in hospital following transsphenoidal surgery (a procedure where the surgeon accesses the pituitary gland through the nose). You can typically return to light activities within a couple of weeks and resume normal activities within several weeks. Some patients experience temporary nasal congestion, headaches, or fatigue during recovery. Your medical team will provide specific guidance based on your procedure and individual circumstances.

Can pituitary tumours affect fertility?

Yes, certain pituitary tumours can impact fertility in both men and women. Prolactinomas (tumours that produce excess prolactin, a hormone that affects reproductive function) can disrupt menstrual cycles and ovulation in women and reduce sperm production in men. Other hormone-secreting tumours can also affect reproductive function. Fertility may improve with suitable treatment. If you’re concerned about fertility, discuss this with your doctor, who can coordinate care with reproductive specialists if needed.

How often will I need follow-up appointments?

Follow-up frequency varies based on your tumour type and treatment. Initially, you may need regular appointments for hormone testing (blood tests to check your hormone levels) and possibly imaging (scans such as an MRI to monitor the tumour). Once your condition is stable, follow-up may become less frequent. Even patients with well-controlled conditions typically require lifelong monitoring, as pituitary tumours can recur. Your healthcare professional will establish a suitable follow-up schedule tailored to your individual risk factors and specific situation.

Can lifestyle changes help manage my pituitary tumour?

Whilst lifestyle changes cannot eliminate a pituitary tumour, they can support your overall health during treatment and recovery. Maintaining a healthy weight, eating a balanced diet, exercising regularly (as appropriate for your condition), getting adequate sleep, and managing stress can help optimise your wellbeing. Some hormonal conditions may benefit from specific dietary modifications. Your medical team can provide personalised recommendations based on your specific needs.

Conclusion

Pituitary tumour treatment in Singapore offers patients access to comprehensive diagnostic services and a full range of evidence-based therapies. Whether your treatment involves medication, surgery, radiation, or careful monitoring, the goal remains the same: controlling your tumour whilst preserving your quality of life.

 

Understanding your condition empowers you to participate actively in treatment decisions and communicate with your medical team. Whilst a pituitary tumour diagnosis may feel overwhelming initially, many patients can achieve positive outcomes with appropriate care.

 

Regular follow-up remains important even after treatment. Ongoing monitoring helps detect any changes promptly. With proper management, most individuals with pituitary tumours can lead full, active lives.

Take the First Step Towards Better Health

Living with a pituitary tumour can be challenging, but you don’t have to face it alone. Our neurosurgeon can provide qualified expertise in diagnosing and treating pituitary tumours using evidence-based approaches.

If you have concerns about pituitary tumours or hormone-related symptoms, speak with a healthcare provider about appropriate evaluation and testing options.

Dr Ng Zhi Xu

Dr Ng Zhi Xu

Senior Consultant Neurosurgeon

Dr Ng is a fully registered specialist in Neurosurgery, with sub-specialty interests in neurotrauma, neuro-oncology, and spine surgery.

  • Bachelor of Medicine and Bachelor of Surgery (MBBS) from Yong Loo Lin School of Medicine, National University of Singapore 2007
  • Basic Surgical Training at TTSH and KTPH 2008-2010
  • Basic Neurosurgical training NUH and KTPH 2010-2012 (Service Registrar)
  • Advanced Neurosurgical training and residency NUH 2013 – 2017
  • Fellowship training in Neurosurgery at Addenbrooke’s Hospital, Cambridge, United Kingdom from 2015 – 2016
  • Intercollegiate Fellowship of Royal Colleges of Surgery (FRCSGlasg) for Neurosurgery, 2016

During his term in KTPH, he developed a deep interest in teaching and organized numerous General Practice (GP) and nursing forums to promote the sharing of common neurosurgical conditions. While there, he was also the director for residency teaching in KTPH.

Dr Ng has done research collaborations with both National Neuroscience Institute (NNI) and NUH. He currently has ongoing research grants with NUH, which focuses on developing modified stem cell treatment for resistant brain cancers.

Our clinics are under the following

insurance panels

For Singaporeans, Singapore Permanent Residents and Foreigners.
Please speak to our friendly clinic staff about using your insurance plans.

Reach Out To Us

We are committed to providing a one-stop experience, where you’ll receive a meticulous consultation and high-quality service in a comfortable environment.

Get Started

Book An Appointment






    image

    For faster response, Call Us

    (65) 6733 3383